Cohort — Update 30 July 2016

Cohort (AIM: CHRT)

Last close As at 21/11/2024

440.00

11.00 (2.56%)

Market capitalisation

GBP177m

More on this equity

Research: Industrials

Cohort — Update 30 July 2016

Cohort

Analyst avatar placeholder

Written by

Industrials

Cohort

Portugal bolsters growth prospects

FY16 results

Aerospace & defence

30 June 2016

Price

297.5p

Market cap

£121m

€1.20/£

Net cash (£m) at 30 April 2016

19.8

Shares in issue

40.6m

Free float

70%

Code

CHRT

Primary exchange

AIM

Secondary exchange

N/A

Share price performance

%

1m

3m

12m

Abs

(18.5)

(18.3)

1.4

Rel (local)

(18.3)

(20.2)

6.5

52-week high/low

427.5p

290p

Business description

Cohort is an AIM-listed defence and security company operating across five divisions: MASS (26% of FY17e sales); SEA (38%); SCS (13%); MCL (13%) and the recently acquired Portuguese business EID (10%).

Next events

AGM

August 2016

Analysts

Andy Chambers

+44 (0)20 3681 2525

Roger Johnston

+44 (0)20 3077 5722

Cohort is a research client of Edison Investment Research Limited

Cohort reported results in line with market expectations, as well as confirming the initial purchase of the 57% stake in EID in Portugal. FY16 sales and profits modestly beat expectations. EID also looks set to produce better margins than previously anticipated, further enhanced by FX. Growth therefore looks set to continue, with the strong balance sheet enabling further appropriate acquisitions, as well as a growing dividend yield. In the current market turmoil, defence has distinct attractions and our SOP-based fair value currently stands at 387p.

Year end

Revenue (£m)

PBT*
(£m)

EPS*
(p)

DPS
(p)

P/E
(x)

Yield
(%)

04/15

99.9

10.2

20.5

5.0

14.5

1.7

04/16

112.6

12.0

25.0

6.0

11.9

2.0

04/17e

131.5

14.3

26.5

7.0

11.2

2.4

04/18e

143.2

15.6

31.3

8.0

9.5

2.7

Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and one-off tax credit in FY16.

FY16 results exceed expectations

While revenues were broadly as anticipated, Cohort’s profit performance exceeded our expectations for FY16. Organic growth of 5% in sales and 13% in group adjusted operating profit is healthy in the current market environment, further boosted by full contributions from the previous year’s acquisitions MCL and J+S. Stronger than expected performances at MASS and MCL were primarily responsible for the beat. Adjusted EPS rose 33% to 27.18p (or by 22% excluding a one-off tax credit worth 2.20p) from 20.45p in FY15. Cash performance also exceeded expectations due to advances received on UK submarine orders before the year end, with net funds ending the year at £19.8m. The FY16 dividend was increased by 20% to 6.0p as expected, covered more than 4x by earnings.

Resilient defence prospects enhanced by EID

Cohort’s defence prospects in the UK appear to be largely immune to any direct impact from Brexit, due to the long-term nature and operational importance of its major programme exposures. Growth in new equipment budgets is expected to resume in FY19, but could be affected by slower UK economic development. However, export markets remain attractive and the addition of EID will provide direct access in the EU as well as new export markets. Cohort expects to increase the stake to 80% by the end of H1, by purchasing a further 23% stake from the Portuguese government for £3.6m (€4.4m). EID will make a 10-month contribution, continues to grow and is generating mid-teen margins, better than we had envisaged for the defence communications operation.

Valuation: Resilience and growth warrant better

While several UK defence peers in the UK have continued to suffer, Cohort delivers healthy growth. Prospects look bright with a single-digit FY18e P/E and a growing dividend yield having clear attractions at present.

Current trading and outlook

Positive FY16 results

Stronger than expected FY16 results were primarily driven by MASS and MCL. The former saw margins improve significantly on slightly lower sales due to a favourable mix, as secure network activity for education diminished in H2. Prospects for growth remain positive with a healthy pipeline of potential export orders. MCL benefited from increased product volumes with lower margins than the traditional support activity. These add greater sales visibility and support future growth, especially in tactical hearing protection where deliveries commenced to the British Army.

SEA continued to work through its strong order book and benefited from a full year contribution from the now integrated J+S during the year.

SCS was slightly constrained by the continuing UK defence budget controls and the absence of any Afghanistan operational contribution, which was still running down in FY15. SCS is expected to remain flat in the forecast period.

The group order book did decline as Cohort traded against its major contracts especially on submarine external communications systems (ECS). Order intake of £94.8m was achieved against a strong comparator (FY15: £114.3m, which included significant ECS orders). In addition, management has identified £60m of renewals that it anticipates in the current year. The backlog now stands at £116m (FY15: £134m), of which £65m is for FY17 delivery, giving FY17 order cover of 55% for the continuing activities. This excludes EID’s order book, where current year cover is said to be stronger than for the existing group. Management does not expect to be affected by the adjustment to single-source MoD business, as all contracts were either originally contested or are below the £5m value threshold.

EID acquisition progressing

The simultaneous announcement of the first stage of the EID acquisition in Portugal is also encouraging. Cohort has acquired its initial 57% stake from existing shareholders for £8.9m in line with the originally announced terms. It now expects to increase this to 80% by the half year through the purchase for a further £3.6m of a 23% government stake, which will then retain a 20% minority.

Performance of EID in 2015 was ahead of our expectations (sales €18.7m, EBIT €2.9m) and the company has continued to grow in H1 with low to mid-teen margins. It will be immediately EPS accretive, extends Cohort’s geographic reach and customer base, while adding technical and manufacturing capabilities. The fall in sterling following the Brexit vote also boosts the contribution on translation.

FY17 profit estimate increases modestly

Our current year profit estimate has been revised up modestly, largely reflecting the increase in margin for EID compared to our previous forecasts. As it only contributes for 10 months rather than a full year, the sales number declines slightly. FY17 should see healthy growth, although the one-off tax adjustment distorts EPS progression, and EPS actually decline marginally compared to our previous forecast due to the allocation of PPA intangible amortisation to the minorities.

Exhibit 1: Changes to previous estimates

Sales (£m)

PBT (£m)

EPS (p)

Old

New

% change

Old

New

% change

Old

New

% change

2016*

112.3

112.6

0.3

11.5

12.0

4.3

21.8

25.0

14.7

2017e

132.4

131.5

(0.9)

14.2

14.3

0.7

26.7

26.5

(0.8)

Source: Company reports; Edison Investment Research estimates. Note: Excludes FY16 tax credit for EPS.
*FY16 old sales and PBT forecasts exclude contribution from EID, which did not complete until June 2016.

The expectation is that, due to EID and the probable £5.5m acquisition of the MCL minority in the current year, net funds will reduce significantly to c £5m. We expect a return to cash generation thereafter. During the year Cohort signed a substantial new £25m banking facility that should support growth ambitions.

Implications of Brexit on defence

While in the near term Brexit may provide a boost to aerospace manufacturing through a sharp depreciation in sterling, the main concern is over the longer term commitment of global aerospace prime contractors to the UK. We see little likely change for the defence sector, which will be driven by existing long-term geopolitical risks and response strategies. However, any reduction in GDP could renew pressure on the UK defence budget, even if we maintain the 2% spending commitment to NATO. The danger for the longer term is that the key elements of strategic capabilities continue to be undermined, although in naval, for example, these seem to be well protected at present as well as by long-term collaborative programmes in other sectors such as air systems and missiles.

Valuation

The immediate impact of the Brexit vote has clearly been to affect market multiples and defence companies have not been immune. This has been exacerbated during H116 by a number of the company’s defence peers facing more company-specific issues that had led to significant de-rating ahead of the Brexit vote. We have moved the SOP valuation to a 2017 calendarised basis using our new FY18 forecast for Cohort.

Exhibit 2: Cohort sum-of-the-parts calculation (calendar 2017 basis) summary

 

EBITA (CY17)

Tax
(%)

NOPAT (CY17)

P/E
(x)

Value
(£m)

Notes

SCS

1.3

16.0%

1.1

12.6

14

10% discount to QinetiQ (14.0x)

MASS

6.3

16.0%

5.3

12.2

64

Average of QinetiQ (14.0x), Ultra (11.8x) & Cobham (10.7x)

SEA

6.0

16.0%

5.0

12.9

65

Average of QinetiQ (14.0x) and Ultra (11.8x)

MCL

1.9

16.0%

1.6

10.1

17

10% discount to Ultra (11.8x) and Cobham (10.7x)

EID

2.2

16.0%

1.8

12.9

24

Average of QinetiQ (14.0x) and Ultra (11.8x)

Less minority in MCL

-6

Carrying value

Less head office costs

-25

Calendarised central costs (12.4x PER)

EV

152

Net cash

5

FY17e net cash

Implied equity value

157

Shares in issue

41

Value per share (p)

 

 

 

 

387

 

Source: Edison Investment Research estimates

Exhibit 3: Financial summary

£m

2013

2014

2015

2016

2017e

2018e

Year end 30 April

IFRS

IFRS

IFRS

IFRS

IFRS

IFRS

PROFIT & LOSS

Revenue

 

 

70.9

71.6

99.9

112.6

131.5

143.2

Cost of Sales

(47.6)

(47.8)

(70.0)

(77.0)

(79.3)

(81.7)

Gross Profit

23.2

23.7

29.9

35.6

52.2

61.5

EBITDA

 

 

7.9

8.8

11.0

13.0

15.1

16.4

Operating Profit (before amort. and except.)

7.3

8.2

10.1

11.9

14.3

15.6

Intangible Amortisation

(0.7)

(0.1)

(3.6)

(6.4)

(9.0)

(9.0)

Exceptionals

1.8

(1.5)

(0.6)

(0.3)

0.0

0.0

Other

0.0

0.0

0.0

0.0

0.0

0.0

Operating Profit

8.4

6.6

5.9

5.2

5.3

6.6

Net Interest

0.1

0.1

0.1

0.1

(0.0)

(0.0)

Profit Before Tax (norm)

 

 

7.5

8.3

10.2

12.0

14.3

15.6

Profit Before Tax (FRS 3)

 

 

8.5

6.7

5.9

5.3

5.3

6.6

Tax

(0.2)

(0.8)

(0.7)

0.1

(0.8)

(1.1)

Profit After Tax (norm)

7.2

7.7

7.8

10.6

12.0

13.1

Profit After Tax (FRS 3)

8.3

5.9

5.2

5.4

4.4

5.6

Average Number of Shares Outstanding (m)

40.2

40.0

40.1

40.6

40.6

40.6

EPS - normalised (p)

 

 

17.9

19.1

20.5

27.2

26.5

31.3

EPS - normalised and fully diluted (p)

 

17.7

18.7

20.0

26.6

26.5

31.3

EPS - (IFRS) (p)

 

 

20.8

14.7

14.0

19.1

14.6

14.3

Dividend per share (p)

3.5

4.2

5.0

6.0

7.0

8.0

Gross Margin (%)

32.8

33.1

29.9

31.6

39.7

42.9

EBITDA Margin (%)

11.2

12.3

11.1

11.5

11.5

11.5

Operating Margin (before GW and except.) (%)

10.4

11.4

10.1

10.6

10.8

10.9

BALANCE SHEET

Fixed Assets

 

 

38.8

38.2

66.2

60.5

65.3

56.3

Intangible Assets

31.5

29.4

55.7

49.5

53.0

44.0

Tangible Assets

6.9

8.5

10.3

10.2

11.5

11.5

Investments

0.5

0.3

0.1

0.8

0.8

0.8

Current Assets

 

 

36.0

39.6

40.3

53.1

45.4

54.7

Stocks

0.2

0.3

1.1

2.0

5.5

5.8

Debtors

19.4

23.0

19.5

28.0

32.0

33.5

Cash

16.4

16.3

19.7

23.1

7.9

15.4

Other

0.0

0.0

0.0

0.0

0.0

0.0

Current Liabilities

 

 

(15.1)

(15.0)

(26.8)

(40.1)

(35.1)

(32.5)

Creditors

(15.1)

(15.0)

(26.8)

(36.8)

(31.8)

(29.2)

Short term borrowings

0.0

0.0

(0.0)

(3.3)

(3.3)

(3.3)

Long Term Liabilities

 

 

(0.7)

(0.6)

(16.8)

(2.7)

(2.7)

(2.7)

Long term borrowings

0.0

0.0

0.0

(0.0)

(0.0)

(0.0)

Other long term liabilities

(0.7)

(0.6)

(16.8)

(2.7)

(2.7)

(2.7)

Net Assets

 

 

59.0

62.2

62.8

70.8

72.9

75.8

CASH FLOW

Operating Cash Flow

 

 

5.2

3.6

20.5

8.5

4.1

13.4

Net Interest

0.1

(0.9)

0.1

0.1

0.2

0.2

Tax

(1.1)

0.0

(1.7)

(1.8)

(2.4)

(2.4)

Capex

(0.3)

(2.3)

(1.1)

(1.0)

(2.1)

(0.8)

Acquisitions/disposals

0.0

2.5

(13.4)

(0.7)

(12.5)

0.0

Financing

(0.4)

(1.5)

0.8

(3.2)

0.0

0.0

Dividends

(1.2)

(1.5)

(1.8)

(2.2)

(2.5)

(2.9)

Net Cash Flow

2.3

(0.1)

3.5

(0.3)

(15.2)

7.5

Opening net debt/(cash)

 

 

(14.1)

(16.4)

(16.3)

(19.7)

(19.8)

(4.6)

HP finance leases initiated

0.0

0.0

0.0

0.0

0.0

0.0

Other

0.0

(0.0)

(0.1)

0.5

0.0

0.0

Closing net debt/(cash)

 

 

(16.4)

(16.3)

(19.7)

(19.8)

(4.6)

(12.1)

Source: Company reports, Edison Investment Research. Note: Normalised EPS in FY16 includes FY16 tax credit.

Edison, the investment intelligence firm, is the future of investor interaction with corporates. Our team of over 100 analysts and investment professionals work with leading companies, fund managers and investment banks worldwide to support their capital markets activity. We provide services to more than 400 retained corporate and investor clients from our offices in London, New York, Frankfurt, Sydney and Wellington. Edison is authorised and regulated by the Financial Conduct Authority. Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison and is not regulated by the Australian Securities and Investment Commission. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com

DISCLAIMER
Copyright 2016 Edison Investment Research Limited. All rights reserved. This report has been commissioned by Cohort and prepared and issued by Edison for publication globally. All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report. Opinions contained in this report represent those of the research department of Edison at the time of publication. The securities described in the Investment Research may not be eligible for sale in all jurisdictions or to certain categories of investors. This research is issued in Australia by Edison Aus and any access to it, is intended only for "wholesale clients" within the meaning of the Australian Corporations Act. The Investment Research is distributed in the United States by Edison US to major US institutional investors only. Edison US is registered as an investment adviser with the Securities and Exchange Commission. Edison US relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. As such, Edison does not offer or provide personalised advice. We publish information about companies in which we believe our readers may be interested and this information reflects our sincere opinions. The information that we provide or that is derived from our website is not intended to be, and should not be construed in any manner whatsoever as, personalised advice. Also, our website and the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. This document is provided for information purposes only and should not be construed as an offer or solicitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.
Edison has a restrictive policy relating to personal dealing. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report. Edison or its affiliates may perform services or solicit business from any of the companies mentioned in this report. The value of securities mentioned in this report can fall as well as rise and are subject to large and sudden swings. In addition it may be difficult or not possible to buy, sell or obtain accurate information about the value of securities mentioned in this report. Past performance is not necessarily a guide to future performance. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (ie without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision. To the maximum extent permitted by law, Edison, its affiliates and contractors, and their respective directors, officers and employees will not be liable for any loss or damage arising as a result of reliance being placed on any of the information contained in this report and do not guarantee the returns on investments in the products discussed in this publication. FTSE International Limited (“FTSE”) © FTSE 2016. “FTSE®” is a trade mark of the London Stock Exchange Group companies and is used by FTSE International Limited under license. All rights in the FTSE indices and/or FTSE ratings vest in FTSE and/or its licensors. Neither FTSE nor its licensors accept any liability for any errors or omissions in the FTSE indices and/or FTSE ratings or underlying data. No further distribution of FTSE Data is permitted without FTSE’s express written consent.

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 9258 1161

Level 25, Aurora Place

88 Phillip St, Sydney

NSW 2000, Australia

Wellington +64 (0)48 948 555

Level 15, 171 Featherston St

Wellington 6011

New Zealand

Frankfurt +49 (0)69 78 8076 960

Schumannstrasse 34b

60325 Frankfurt

Germany

London +44 (0)20 3077 5700

280 High Holborn

London, WC1V 7EE

United Kingdom

New York +1 646 653 7026

245 Park Avenue, 39th Floor

10167, New York

US

Sydney +61 (0)2 9258 1161

Level 25, Aurora Place

88 Phillip St, Sydney

NSW 2000, Australia

Wellington +64 (0)48 948 555

Level 15, 171 Featherston St

Wellington 6011

New Zealand

More on Cohort

View All

Latest from the Industrials sector

View All Industrials content

RNTS Media — Update 29 July 2016

RNTS Media

Continue Reading

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free